1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
DoD Peer Reviewed Cancer Research, Impact Award is sponsored by Department of Defense (DoD), Defense Health Agency Contracting Activity - DHACA. This award mechanism encourages applications with mature research projects that specifically focus on critical scientific or clinical cancer issues, which, if successfully addressed, have the potential to make a major impact on at least one of the FY20 PRCRP Topic Areas.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar DoD Peer Reviewed Cancer, Impact Award Defense Health Agency Contracting Activity - DHACA Document Type:Grants Notice Funding Opportunity Number:W81XWH-18-PRCRP-IPA Funding Opportunity Title:DoD Peer Reviewed Cancer, Impact Award Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Grant Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards:9 Assistance Listings:12.
420 -- Military Medical Research and Development Cost Sharing or Matching Requirement:No Original Closing Date for Applications:Sep 26, 2018 Current Closing Date for Applications:Sep 26, 2018 Archive Date:Oct 26, 2018 Estimated Total Program Funding:$ 14,400,000 Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:Defense Health Agency Contracting Activity - DHACA Description:The FY18 PRCRP Impact Award supports hypothesis-driven, **_high-impact_**research.
The Impact Award mechanism encourages applications that research projects or ideas that specifically focus on critical scientific and clinical cancer issues, which, if successfully addressed, have the potential to make a major impact on at least one of the FY18 PRCRP Topic Areas. Important factors under consideration will be continuity of research, clinical applicability, and leveraging of clinical samples and trials.
Through the Impact Award, the PRCRP seeks to build foundations for finding cures in under-funded, under-studied, and/or lethal militarily relevant cancer areas. With the Impact Award, PRCRP offers the unique opportunity to find commonalities in research across multiple cancers that advance the broader cancer field and to address cancer funding disparities within the FY18 PRCRP Topic Areas.
The Impact Award supports identifying scientific outcomes through rigorous, robust research that are translatable toward treatment and/or preventive strategies. Research proposed should aim to accelerate promising findings toward clinical applicability and leverage research results to maximize impact.
**_The critical components of this award mechanism are:_****Impact:**The Impact Award is intended to support research that demonstrates the potential to have a major impact on an area of paramount importance in cancer.
It is the responsibility of the Principal Investigator (PI) to clearly and explicitly describe the potential impact of the proposed study on at least one of the FY18 PRCRP Topic Areas and to convey its level of significance. Proposed projects may include translational or clinical research, including clinical trials, and **_must_**demonstrate clear clinical relevance.
**_The potential impact of the proposed research is expected to be near-term and it must be significant and go beyond an incremental advance_**. The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will, if successful, accelerate the movement of promising ideas into clinical applications.
**Transformative Research:**The Impact Award is intended to support transformative investigations that leapfrog the cancer research field forward by utilizing previous research findings. The proposed study should demonstrate how the research will transform cancer research toward improved patient care in at least one of the FY18 PRCRP Topic Areas and have potential near-term outcomes.
The research should make a significant shift toward clinical applicability in at least one of the FY18 PRCRP Topic Areas. Research should challenge paradigms with respect to the endpoint of impact on patient care and outcomes. Research should seek to find commonalities in cancer research to advance the understanding of the cancer field while focusing on at least one of the FY18 PRCRP Topic Areas.
**Continuity of Research:**The Impact Award is intended to support established projects that have moved beyond the realm of basic research and have the potential to result in a near-term impact in clinical research or the clinic. **Preliminary Data:**Applications **_must include preliminary data_**to support feasibility of the study.
Any unpublished, preliminary data provided should originate from the laboratory of the PI or a member(s) of the research team. **Military Relevance:**The proposed research must address at least one of the FY18 PRCRP Military Relevance Focus Areas. The proposed research must be relevant to active duty Service members, Veterans, and their beneficiaries.
For more information, review the following websites: PRCRP (http://cdmrp. army. mil/prcrp/default); PRCRP Report to Congress (http://cdmrp.
army. mil/prcrp/reports/reports); Military Health System (MHS) (http://www. health.
mil); VA (http://www. va. gov/).
The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public. The anticipated direct costs budgeted for the entire period of performance for an FY18 PRCRP Impact Award will not exceed **$1,000,000. **Refer to Section II.
D. 5, Funding Restrictions, for detailed funding information. Link to Additional Information:[](https://www.
grants. gov/search-results-detail/304593) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below.
This is being done to protect your privacy. Unsaved changes will be lost.
According to the current listing, eligibility includes: Eligible applicants include organizations, academic institutions, researchers, and individuals. Confirm the full requirements in the official notice before applying.
DoD Peer Reviewed Cancer Research, Impact Award is funded by Department of Defense (DoD), Defense Health Agency Contracting Activity - DHACA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article